Our CEO Miquel Vila-Perelló shared his views on the personalized approach ProteoDesign is developing to fight cancer, along with other entrepreneurs in the field.
- ProteoDesign secures a 1.7M€ financing round led by Caixa Capital Risc
- ProteoDesign to attend BIO-Europe Spring 2018 in Amsterdam
- ProteoDesign’s fight against cancer featured in “ARA” newspaper
- Miquel Vila-Perelló interviewed by the CataloniaBio newsletter
- ProteoDesign leads the ToxAb consortium awarded with a “RETOS de Colaboración” grant